Texas' Medical Cannabis Program Is Open For Business

Ron Strider

Well-Known Member
AUSTIN, Texas - November 1, 2017 - Compassionate Cultivation is ready to make history in the Lone
Star State by planting one of Texas' first legal cannabis crops.

The medical cannabis company – one of two businesses licensed to grow cannabis that is high in
non-psychoactive cannabidiol (CBD) and low in psychoactive tetrahydrocannabinol (THC) in
Texas – received its state license today and will immediately start cultivating its first crop inside its
vertically integrated Austin facility.

"Our business philosophy is built around a world-class team and responsible leadership that exceeds the
state's expectations," says Compassionate Cultivation CEO Morris Denton. "And most importantly we're
excited to deliver on the promise of low-THC cannabis to the Texas medical community – and to the
many patients and families hoping that CBD-rich cannabis oil can help stop the cycle of suffering."
The Texas Compassionate Use Act, signed by Gov. Greg Abbott in 2015, legalized the cultivation of
CBD-rich cannabis–and the sale of an oil derived from that cannabis – to patients suffering from
intractable epilepsy. Compassionate Cultivation won one of the state's licenses to cultivate plants and
extract and retail the cannabis oil earlier this summer.

Pending final approval from the Texas Department of Public Safety, Compassionate Cultivation plans to
start selling its cannabis oil as early as January 2018–after the first batch of plants are harvested and
cured, after the oil is extracted from the plant matter, and after the oil has been tested for purity and
safety.

Compassionate Cultivation has enlisted industry-leading cannabis management consultancy
MJardin–which provides turn-key cultivation and processing services–to operate its grow, thus
completing a team that is as esteemed as it is passionate.

Another essential team member is Compassionate Cultivation chief medical officer Dr. Karen Keough, a
Board Certified Child Neurologist who specializes in treating intractable epilepsy at Child Neurology
Consultants of Austin.

"The medical community has struggled to understand CBD, and even though we still have a long way to
go, we've learned so much that has legitimized this cannabis-based medicine over the last three-to-five
years, but especially in the last six months –and this is only the beginning," says Dr. Keough, who also
chairs the Child Neurology Society's Educational Special Interest Group and serves on the Neurology
Child Examination Committee for the American Board of Psychiatry and Neurology. "My partners and I
are looking forward to responsibly integrating CBD into our treatment regimens, and I very much look
forward to helping other physicians better understand CBD and how it may help some of their patients.
"I know many of my patients are incredibly excited about this. For them, it's a new and promising
opportunity to manage this devastating neurological disorder when more traditional options just aren't
working."

As Dr. Keough wrote in a recent Texas Tribune column, "I myself have gone from cautioning patients not
to expect too much from CBD to saying, 'Let's see what happens,' to realizing that, for many patients,
CBD not only meets their needs but exceeds all of our expectations. And now I look forward to 2018,
when we'll finally be able to deliver this important plant-based medicine to the Texans who need it
most."

Compassionate Cultivation's operations partner MJardin–which currently manages over 30 licensed
cultivation facilities in 13 U.S. states and two countries–has an exceptional track record in operating
cannabis facilities. MJardin facilities have produced well over 150,000 pounds of consistently
high-quality finished product since its inception in 2014, making it the largest cultivator of legal cannabis
in the world.

"MJardin and the Compassionate Cultivation team have worked seamlessly throughout the process thus
far," says MJardin Chairman and CEO Rishi Gautam. "And the fact that we are about to achieve an
unprecedented five-month stand up from provisional license to final license is a testament to the level
of expertise this team will bring to the medical cannabis community of Texas."

MJardin will partner with Compassionate Cultivation to implement rigorous quality control measures in
compliance with Texas legislative requirements to ensure consistency of product and freedom from
contaminants.

About Compassionate Cultivation

Compassionate Cultivation is a home-grown medical cannabis company serving patients throughout
America's second-most populous state. As the only Texas-licensed cannabis business from the Lone Star
State, Compassionate Cultivation is dedicated to representing the integrity of this great land and helping
patients and families in need–and the physicians recommending their cannabis-based medicine. For
more information, please visit compassionatecultivationtx.com .

About MJardin

MJardin Management is a highly specialized professional operating company that develops partnerships
with licensed operators. MJardin provides their partners turnkey cannabis cultivation and processing
solutions including licensure support, facility design, systems implementation, facility ramp-up and the
day-to-day operational management required in a large-scale, professionally managed cannabis facility.

For more information, please visit MJardin.com.

Media Contacts

For more information on Compassionate Cultivation:

Nora Olabi, Grasslands: nora@mygrasslands.com , 832-419-2515

For more information on MJardin:

Kara Devine, MJardin: kara.devine@mjardin.com , 720-613-4019

News Moderator: Ron Strider 420 MAGAZINE ®
Author: Nora Olabi
Contact: CONTACT | MJardin | Professional Cannabis Cultivation
Website: MJardin | MMJ Cultivation Management | Cannabis Consultants | Medical Marijuana Consulting & Turnkey Cultivation Management

Welcome to the 420 Press Release Forum, created as a service to our readers solely for the dissemination of cannabis and hemp industry related press releases.

It is important for us to state that all press release information published on 420Magazine.com is ONLY based on what companies and individuals (i.e. third parties not associated with 420 Magazine) publish themselves and doesn't involve any 420 Magazine's editorial opinion or review. 420 Magazine takes no responsibility for and disclaims the information available in form of press releases across our website.

Some press releases may be confusing at first reading without additional explanation. In such case you should contact the press release author, either the company or the individual listed as the contact on the press release itself, with any additional questions regarding the information presented on their press release.

420 Magazine has zero tolerance towards objectionable and controversial PR materials published on its website. Any PR material found to be involved into a dispute, in one way or another, and is having one or more complaints received at 420 Magazine, against it supported with enough evidences that clearly indicate, in one way or another, it is harmful, even in a remote way, to the interest of 3rd parties is ground for taking the respective press release permanently down, without prior notice.
 
Back
Top Bottom